Literature DB >> 24296432

Challenges and possibilities in forward resuscitation.

Timothy James Hooper1, Marc De Pasquale, Geir Strandenes, Geir Sunde, Kevin R Ward.   

Abstract

The environmental and logistical constraints of the prehospital setting make it a challenging place for the treatment of trauma patients. This is perhaps more pronounced in the management of battlefield casualties before extraction to definitive care. In seeking solutions, interest has been renewed in implementing damage control resuscitation principles in the prehospital setting, a concept termed remote damage control resuscitation. These developments, while improving conflict survival rates, are not exclusive to the military environment, with similar situations existing in the civilian setting. By understanding the pathophysiology of shock, particularly the need for oxygen debt repayment, improvements in the assessment and management of trauma patients can be made. Technology gaps have previously hampered our ability to accurately monitor the prehospital trauma patient in real time. However, this is changing, with devices such as tissue hemoglobin oxygen saturation monitors and point-of-care lactate analysis currently being refined. Other monitoring modalities including newer signal analysis and artificial intelligence techniques are also in development. Advances in hemostatic resuscitation are being made as our understanding and ability to effectively monitor patients improve. The reevaluation of whole-blood use in the prehospital environment is yielding favorable results and challenging the negative dogma currently associated with its use. Management of trauma-related airway and respiratory compromise is evolving, with scope to improve on currently accepted practices. The purpose of this review is to highlight the challenges of treating patients in the prehospital setting and suggest potential solutions. In doing so, we hope to maintain the enthusiasm from people in the field and highlight areas for prehospital specific research and development, so that improved rates of casualty survival will continue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24296432     DOI: 10.1097/SHK.0000000000000096

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

Review 1.  Physiological comparison of hemorrhagic shock and V˙ O2max: A conceptual framework for defining the limitation of oxygen delivery.

Authors:  Victor A Convertino; Kristen R Lye; Natalie J Koons; Michael J Joyner
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-01

Review 2.  Remote Damage Control Resuscitation in Austere Environments.

Authors:  Ronald Chang; Brian J Eastridge; John B Holcomb
Journal:  Wilderness Environ Med       Date:  2017-06       Impact factor: 1.518

3.  An Automated Hardware-in-Loop Testbed for Evaluating Hemorrhagic Shock Resuscitation Controllers.

Authors:  Eric J Snider; David Berard; Saul J Vega; Sofia I Hernandez Torres; Guy Avital; Emily N Boice
Journal:  Bioengineering (Basel)       Date:  2022-08-07

4.  Pre-hospital blood transfusion - an ESA survey of European practice.

Authors:  Karl-Christian Thies; Anatolij Truhlář; Damian Keene; Jochen Hinkelbein; Kurt Rützler; Luca Brazzi; Benoît Vivien
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-08-14       Impact factor: 2.953

5.  Validation of a point-of-care capillary lactate measuring device (Lactate Pro 2).

Authors:  Anette Raa; Geir Arne Sunde; Bjørn Bolann; Reidar Kvåle; Christopher Bjerkvig; Håkon S Eliassen; Tore Wentzel-Larsen; Jon-Kenneth Heltne
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-08-18       Impact factor: 2.953

Review 6.  Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center.

Authors:  James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.